Tissue Sample Study for Mitochondrial Disorders

Part of paid clinical trials in New York, New York.

Sponsor
Columbia University
Study ID
NCT01803906
Status
Enrolling By Invitation

Conditions

  • Kearns Sayer
  • LHON
  • Leigh's Disease
  • MNGIE
  • Melas
  • Mitochondrial Depletion Syndrome
  • Mitochondrial Disease
  • Mitochondrial Disorders
  • NARP

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Accepted

Study Details

The investigators are studying patients with undefined mitochondrial diseases to identify genetic mutations in nuclear or mitochondrial Deoxyribonucleic Acid (DNA). Most patients with suspected or known mitochondrial diseases have no genetic confirmation. The investigators expect that evaluating tissue samples from patients with mitochondrial disorders will lead us to discover mutations in new or known genes causing mitochondrial dysfunction.

Key Dates

Start date
Feb 29, 2012
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
6,900 participants (estimated)

Arms

  • Arm: Mitochondrial disease
    Patients with known or suspected DNA mutations that affect mitochondrial function. Patients with suspected mitochondrial disorders

Primary Outcome Measure

Number of patients with reduced respiratory chain enzyme levels [ Time Frame: Up to 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Columbia UniversityNew YorkNew York10032-

Find similar trials in New York, NY

Related Studies